Research Publications

Research Publications

  • ■■2021年■■

    Grafting of iPS cell-derived tenocytes promotes motor function recovery after Achilles tendon rupture
    Nakajima T, Nakahata A, Yamada N, Yoshizawa K, Kato TM, Iwasaki M, Zhao C, Kuroki H, Ikeya M
    Nature Communications 12: 5012 doi: 10.1038/s41467-021-25328-6 (2021)

  • Transplantation of human autologous synovial mesenchymal stem cells with trisomy 7 into the knee joint and 5 years of follow-up
    Mizuno M, Endo K, Katano H, Amano N, Nomura M, Yoshinori Hasegawa, Nobutake Ozeki, Hideyuki Koga, Takasu N, Osamu Ohara, Tomohiro Morio, Ichiro Sekiya
    Stem Cell Research Volume 50 102033 doi :10.1016/j.scr.2020.102033 (2021)

  • CiRA iPSC seed stocks (CiRA's iPSC Stock Project)
    Hanatani T, Takasu N
    Stem Cell Research Volume 50 102033 doi :10.1016/j.scr.2020.102033 (2021)

  • ■■2020年■■

    Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson's disease
    Doi D, Magotani H, Kikuchi T, Ikeda M, Hiramatsu S, Yoshida K, Amano N, Nomura M, Umekage M, Morizane A, Takahashi J
    Nat Commun 11: 3369 doi: 10.1038/s41467-020-17165-w (2020)

  • HLA-Matched Allogeneic iPS Cells-Derived RPE Transplantation for Macular Degeneration
    Sugita S, Mandai M, Hirami Y, Takagi S, Maeda T, Fujihara M, Matsuzaki M, Yamamoto M, Iseki K, Hayashi N, Hono A, Fujino S, Koide N, Sakai N, Shibata Y, Terada M, Nishida M, Dohi H, Nomura M, Amano N, Sakaguchi H, Hara C, Maruyama K, Daimon T, Igeta M, Oda T, Shirono U, Tozaki M, Totani K, Sugiyama S, Nishida K, Kurimoto Y, Takahashi M
    J Clin Med 9(7): 2217 doi: 10.3390/jcm9072217 (2020)

  • ■■2019年■■

    Overview: an iPS cell stock at CiRA
    Umekage M, Sato Y, Takasu N
    Inflamm Regener 39: 17 doi: 10.1186/s41232-019-0106-0 (2019)

  • Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility
    Xu H, Wang B, Ono M, Kagita A, Fujii K, Sasakawa N, Ueda T, Gee P, Nishikawa M, Nomura M, Kitaoka F, Takahashi T, Okita K, Yoshida Y, Kaneko S, Hotta A
    Cell Stem Cell 24(4):566-578.e7 doi: 10.1016/j.stem (2019)

  • ■■2018年■■

    Quality control guidelines for clinical-grade human induced pluripotent stem cell lines
    Sullivan S, Stacey GN, Akazawa C, Aoyama N, Baptista R, Bedford P, Griscelli AB, Chandra A, Elwood N, Girard M, Kawamata S, Hanatani T, Latsis T, Lin S, Ludwig TE, Malygina T, Mack A, Mountford JC, Noggle S, Pereira L, Price J, Sheldon M, Srivastava A, Stachelscheid H, Velayudhan SR, Ward NJ, Turner ML, Barry J, Song J.
    Regen Med 13:859 doi: 10.2217/rme-2018-0095 (2018) 

  • Report of the international conference on manufacturing and testing of pluripotent stem cells
    Abbot S, Agbanyo F, Ahlfors JE, Baghbaderani BA, Bartido S, Bharti K, Burke C, Carlsson B, Cavagnaro J, Creasey A, DiGiusto D, Francissen K, Gaffney A, Goldring C, Gorba T, Griffiths E, Hanatani T, Hayakawa T, Heki T, Hoogendoorn K, Kawamata S, Kimura H, Kirkeby A, Knezevic I, Lebkowski J, Lin S, Lin-Gibson S, Lubiniecki A, O'Shea O, Pera M, Petricciani J, Pigeau G, Ratcliffe A, Sato Y, Schumann GG, Shingleton W, Stacey Chair G, Sullivan S, Svendsen CN, Trouvin JH, Vandeputte J, Yuan BZ, Zoon K.
    Biologicals 56:67 doi: 10.1016/j.biologicals.2018.08.004 (2018)